Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment

Navasa, 2004, Bacterial infections in cirrhosis, Liver Int., 24, 277, 10.1111/j.1478-3231.2004.0934.x NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consensus State Science Statements. June 10–12, 2002;19 (3):1–46. Soza, 2002, Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C, Hepatology, 36, 1273, 10.1053/jhep.2002.36502 Simon, 2004, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis, Clin Infect Dis, 39, 206, 10.1086/421997 Elefsiniotis, 2006, Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease, Eur J Gastroenterol Hepatol, 18, 525, 10.1097/00042737-200605000-00012 Maruna, 2000, Physiology and genetics of procalcitonin, Physiol Res, 49, S57